Search…

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    AstraZeneca in talks for £300bn merger

    1 hour ago

    3

    0

    AstraZeneca is reportedly in discussions with US rival Bristol Myers Squibb regarding a potential merger valued at over £300 billion. This deal could create the world's fourth largest pharmaceutical company. However, regulatory hurdles may pose challenges, and sources indicate that the negotiations could either progress or fall apart in the near future.
    Click here to Read more
    Prev Article
    Migrant rush into Ceuta death toll rises to 72
    Next Article
    FAW withdraws support for Gianni Infantino

    Related Business Updates:

    Comments (0)

      Leave a Comment